Semeiotica Biofisica Quantistica. Il Nuovo Rinascimento della Medicina. www.sisbq.org

Archivio per agosto, 2022

Ultima Mail-J’accuse al Ministro della Salute Roberto Speranza.

——– Messaggio Inoltrato ——–

Oggetto:Fwd: Call for Section Editors: CNS & Neurological Disorders Drug Targets Impact Factor: 2.824
Data:Fri, 5 Aug 2022 14:44:44 +0200
Mittente:Sergio Stagnaro <dottsergio@semeioticabiofisica.it>
A:segreteria ministero sanità <segreteriaministro@sanita.it>

Al Ministro della Salute, Roberto Speranza,

come giustifica la censura imposta alla Semeiotica Biofisica Quantistica da lei e dai suoi compagni di viaggio con il contenuto della seguente mail?

Occultare l’esistenza dei Reali Rischi Congeniti è un crimine contro l’Umanità. Fare la TQMR senza divulgarla è desolante.

Mi auguro, pertanto, che nel prossimo governo lei non figuri.

Saluti

Dr Sergio Stagnaro

90 anni, Medico di MG, pensionato dal 202i

Dr Sergio Stagnaro

Via Erasmo Piaggio 23/8,

16039 Riva Trigoso (Genoa) Italy

Phone 3888770382

Founder of Quantum Biophysical Semeiotics,

Honorary President of International Society of

Quantum Biophysical Semeiotics (SISBQ)

www.semeioticabiofisica.it 

www.sisbq.org

www.sergiostagnaro.wordpress.com

——– Messaggio Inoltrato ——–

Oggetto:Call for Section Editors: CNS & Neurological Disorders Drug Targets Impact Factor: 2.824
Data:Fri, 5 Aug 2022 12:18:18 +0500
Mittente:Editorial Office <editorial@currsmartmat.net>
A:dottsergio@semeioticabiofisica.it

CNS & Neurological Disorders Drug Targets

August 5, 2022 

Dr. S. Stagnaro

International Society of Quantum Biophysical Semeiotics

Lancenigo

Italy

Italy

Dear Dr. S. Stagnaro,

This is a Call for the Appointment of Section Editors, to the journal CNS & Neurological Disorders Drug Targets (CNSNDDT), (Impact Factor 2.824)”. This journal is in its 21st volume and has been abstracted/indexed in several prominent indexing agencies including Science Citation Index Expanded™, SciSearch®, Journal Citation Reports/Science Edition, Scopus etc. The Journal publishes high quality reviews and research papers focusing on hot topics, besides thematic issues in the field of the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

Considering your contributions in the field, and based on your published article entitled “Inherited real risk of schizophrenia: Pathogenesis, bedside diagnosis and primary prevention”, we feel that your field of interest is related to the field of the journal, and you would be a valuable addition to its Board as a Section Editor. We therefore request your permission to communicate with you further on this matter.

The scope of the CNS & Neurological Disorders – Drug Targets covers all areas of neurological and central nervous system (CNS) disorders, including, but not limited to:  

1.        5-HT and Anxiety

2.        5-HT Receptors and Their Function

3.        Acetylcholinesterase Inhibitors

4.        Analgesics

5.        Anticonvulsants

6.        Antidepressants

7.        Antipsichotics

8.        ATP-Mediated Cytotoxicity

9.        Attention Deficit Hyperactivity Disorder

10.      Benzodiazepines

11.      Bipolar Disorder

12.      Blood-Brain Barrier

13.      Brain Disorders

14.      Brain Hemorrhage

15.      Brain-Derived Neurotrophic Factor

16.      Brain Signalling Molecules

17.      Cannabinoids

18.      Clinical Neuroscience

19.      CNS Axon Regeneration

20.      CNS Diseases

21.      Cognitive Neuroscience Section

22.      Dementia

23.      Depressive Disorders

24.      Dopamine and Drug Addiction

25.      Dopamine Receptors and Brain Function

26.      Epilepsy

27.      GABA Receptors

28.      Glutamate Receptors

29.      Melatonin

30.      Metabotropic Glutamate Receptor

31.      Migraine

32.      Mood Stabilizers

33.      Multiple Sclerosis

34.      Neurodegenerative Diseases

35.      Neurodevelopment

36.      Neuroinflammation

37.      Neurogenesis

38.      Neuronal Nicotinic Receptor

39.      Neuropeptide

40.      Neuroprotection

41.      Neuropsychopharmacology

42.      Neurosteroids

43.      Neurotoxicity

44.      Neurotransmitter

45.      Noradrenaline

46.      Obsessive-Compulsive Disorder

47.      Oxidative Stress and Neurodegenerative Diseases

48.      Oxytocin and Eating Disorder

49.      Psychotic Disorders

50.      Schizophrenia

51.      Serotonin

52.      Statins and the Brain

53.      Therapeutics of Alzheimer’s Disease

54.      Traumatic Brain Injury

If you feel that this is something that would interest you, please let us know and we will send you further details regarding the role and benefits of the Section Editors.

We look forward to receiving your positive response.

Sincerely,

Q.Malik

Editorial Manager

Cloud dei tag